171 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Company
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
workforce representation and increased community engagement by the company's employees;
◦Advancing climate action goals and increasing the company's
424B5
BMY
Bristol-Myers Squibb Company
16 Feb 24
Prospectus supplement for primary offering
4:34pm
or indirectly.
According to the depositary, the foregoing information with respect to the depositary has been provided to the financial community
424B2
lt1748q
13 Feb 24
Prospectus for primary offering
8:00am
DFAN14A
7ye eul0bklpjclr
22 Dec 23
Additional proxy materials by non-management
4:36pm
424B5
88uze9iwsxt6hgb
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
yvpxkzn wd0mgqbvdqy
30 Oct 23
Prospectus supplement
8:05am
DEFA14A
2v71t
10 Apr 23
Additional proxy soliciting materials
5:12pm
424B5
fmgyq
17 Feb 22
Prospectus supplement for primary offering
4:47pm
424B3
oo85 jli5
15 Feb 22
Prospectus supplement
9:13am
8-K
EX-99.1
siqw8d 3iclwa
16 Nov 21
Regulation FD Disclosure
9:20am